148 related articles for article (PubMed ID: 37698593)
1. [Moderate hypofractionated adjuvant radiotherapy with simultaneous integrated boost for breast cancer].
Krug D; Dunst J
Strahlenther Onkol; 2023 Nov; 199(11):1033-1035. PubMed ID: 37698593
[No Abstract] [Full Text] [Related]
2. Comment to "Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost".
Kao YS
Radiother Oncol; 2022 Jan; 166():100. PubMed ID: 34856289
[No Abstract] [Full Text] [Related]
3. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
4. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
[TBL] [Abstract][Full Text] [Related]
5. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
7. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant radiation therapy for breast cancer].
Lange T; Knöchelmann AC; Bremer M
Radiologie (Heidelb); 2023 Sep; 63(9):693-702. PubMed ID: 37581632
[TBL] [Abstract][Full Text] [Related]
10. Dual partial arc volumetric-modulated arc therapy: The game changer for accelerated hypofractionated whole-breast radiotherapy with simultaneous integrated tumor cavity boost in early breast cancer - A comparative dosimetric study with single partial arc volumetric-modulated arc therapy.
Mondal D; Julka PK; Sharma DN; Laviraj MA; Jana M; Kamal VK; Deo SVS; Guleria R; Rath GK
J Cancer Res Ther; 2019; 15(5):1005-1010. PubMed ID: 31603102
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of patients with conserved breast cancer treated with adjuvant hypofractionated prone breast intensity-modulated radiation therapy.
Gortman AM; Aherne NJ; Amalaseelan J; Last A; Westhuyzen J; Chamberlain L; Shakespeare TP
J Med Imaging Radiat Oncol; 2020 Dec; 64(6):845-851. PubMed ID: 32543013
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Hong Z; Yang Z; Mei X; Li P; Bao C; Wang Z; Cai X; Ming X; Wang W; Guo X; Yu X; Zhang Q
Radiat Oncol; 2023 Mar; 18(1):56. PubMed ID: 36959653
[TBL] [Abstract][Full Text] [Related]
13. A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery.
Yu T; Li Y; Sun T; Xu M; Wang W; Shao Q; Zhang Y; Li J; Yu J
Sci Rep; 2021 Sep; 11(1):18017. PubMed ID: 34504253
[TBL] [Abstract][Full Text] [Related]
14. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
15. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
[TBL] [Abstract][Full Text] [Related]
16. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study.
Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S;
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues.
Yarnold J; Somaiah N; Bliss JM
Breast; 2015 Nov; 24 Suppl 2():S108-13. PubMed ID: 26249121
[No Abstract] [Full Text] [Related]
20. Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: Comparison with sequential boost in a randomized trial.
Van Hulle H; Desaunois E; Vakaet V; Paelinck L; Schoepen M; Post G; Van Greveling A; Speleers B; Mareel M; De Neve W; Monten C; Deseyne P; Veldeman L
Radiother Oncol; 2021 May; 158():62-66. PubMed ID: 33617910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
